2024-12-13 05:34:48
Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification. CITIC Securities: There is no need to be overly pessimistic about the export of home appliances catalyzed by state subsidies. CITIC Securities Research Report said that domestically, the sales data of white electricity and black electricity continued to improve under the support of state subsidies. Externally, the overall export exposure of home appliance enterprises to the United States is relatively limited, so there is no need to be overly pessimistic. Looking forward to the future, the domestic demand stimulus policy is expected to be further overweight, and it is suggested to focus on white power enterprises that benefit from state subsidies; Optional sectors where domestic demand is expected to reverse (small household appliances, projection).
US President-elect Trump: Opposing Ukrainian armed forces to attack Russia with US long-range missiles has further escalated the conflict.Market News: A fire broke out at Kaliningrad Shipyard in Russia.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.
Gao Weibing: Guangzhou Institute will improve the variety layout of new energy and new materials. On December 12th, 2024 China New Energy and New Materials Industry Conference was held in Guangzhou. Gao Weibing, Party Secretary and Chairman of Guangzhou Futures Exchange, said that in the near future, Guangzhou Futures Exchange will launch polysilicon futures and options to form a linkage with industrial silicon, providing more effective price signals and risk management tools for the photovoltaic industry chain. In the next step, Guangzhou Institute will thoroughly implement the spirit of "Opinions on Strengthening Supervision and Preventing Risks to Promote the High-quality Development of Futures Market", based on the fundamental purpose of serving the real economy and the characteristic orientation of serving the green development, improve the variety layout of new energy and new materials, increase market cultivation, continuously enrich the supervision toolbox, and strive to ensure the safe and stable operation of the market and better serve the needs of the real economy. (China Nonferrous Metals News)Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.Morgan Stanley lowered Macy's target price from $17.00 to $16.00.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13